52
2
0
Like?
Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
Browse Other Projects on Experiment
Related Projects
Finding a Cure for Mitochondrial DNA Diseases through COX2 Variations to Restore Cell Function
Inherited and acquired mutations in the mitochondrial DNA can lead to several debilitating diseases, including...
Can cockroaches help us cure tularemia?
Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also...
Making Inexpensive Insulin Using Microalgae
This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae...